Virtual Customer Premises Equipment (V-CPE)
Virtual Customer Premises Equipment (V-CPE) market is segmented by region (country), players, by ... Read More
1 Study Coverage 1.1 Viral Inactivation Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Introduction 1.2 Global Viral Inactivation Outlook 2017 VS 2022 VS 2028 1.2.1 Global Viral Inactivation Market Size for the Year 2017-2028 1.2.2 Global Viral Inactivation Market Size for the Year 2017-2028 1.3 Viral Inactivation Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Viral Inactivation in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Viral Inactivation Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Viral Inactivation Market Dynamics 1.4.1 Viral Inactivation Industry Trends 1.4.2 Viral Inactivation Market Drivers 1.4.3 Viral Inactivation Market Challenges 1.4.4 Viral Inactivation Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Viral Inactivation by Type 2.1 Viral Inactivation Market Segment by Type 2.1.1 Kits and Reagents 2.1.2 Services 2.1.3 Viral Inactivation Systems and Accessories 2.2 Global Viral Inactivation Market Size by Type (2017, 2022 & 2028) 2.3 Global Viral Inactivation Market Size by Type (2017-2028) 2.4 United States Viral Inactivation Market Size by Type (2017, 2022 & 2028) 2.5 United States Viral Inactivation Market Size by Type (2017-2028) 3 Viral Inactivation by Application 3.1 Viral Inactivation Market Segment by Application 3.1.1 Blood and Blood Products 3.1.2 Cellular and Gene Therapy Products 3.1.3 Stem Cell Products 3.1.4 Tissue and Tissue Products 3.1.5 Vaccines and Therapeutics 3.2 Global Viral Inactivation Market Size by Application (2017, 2022 & 2028) 3.3 Global Viral Inactivation Market Size by Application (2017-2028) 3.4 United States Viral Inactivation Market Size by Application (2017, 2022 & 2028) 3.5 United States Viral Inactivation Market Size by Application (2017-2028) 4 Global Viral Inactivation Competitor Landscape by Company 4.1 Global Viral Inactivation Market Size by Company 4.1.1 Top Global Viral Inactivation Companies Ranked by Revenue (2021) 4.1.2 Global Viral Inactivation Revenue by Player (2017-2022) 4.2 Global Viral Inactivation Concentration Ratio (CR) 4.2.1 Viral Inactivation Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Viral Inactivation in 2021 4.2.3 Global Viral Inactivation Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Viral Inactivation Headquarters, Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Type 4.3.1 Global Viral Inactivation Headquarters and Area Served 4.3.2 Global Viral Inactivation Companies Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Viral Inactivation Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Viral Inactivation Market Size by Company 4.5.1 Top Viral Inactivation Players in United States, Ranked by Revenue (2021) 4.5.2 United States Viral Inactivation Revenue by Players (2020, 2021 & 2022) 5 Global Viral Inactivation Market Size by Region 5.1 Global Viral Inactivation Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Viral Inactivation Market Size by Region (2017-2028) 5.2.1 Global Viral Inactivation Market Size by Region: 2017-2022 5.2.2 Global Viral Inactivation Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Viral Inactivation Market Size YoY Growth 2017-2028 6.1.2 North America Viral Inactivation Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Viral Inactivation Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Viral Inactivation Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Viral Inactivation Market Size YoY Growth 2017-2028 6.3.2 Europe Viral Inactivation Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Viral Inactivation Market Size YoY Growth 2017-2028 6.4.2 Latin America Viral Inactivation Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Viral Inactivation Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Viral Inactivation Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Danaher 7.1.1 Danaher Company Details 7.1.2 Danaher Business Overview 7.1.3 Danaher Viral Inactivation Introduction 7.1.4 Danaher Revenue in Viral Inactivation Business (2017-2022) 7.1.5 Danaher Recent Development 7.2 Merck 7.2.1 Merck Company Details 7.2.2 Merck Business Overview 7.2.3 Merck Viral Inactivation Introduction 7.2.4 Merck Revenue in Viral Inactivation Business (2017-2022) 7.2.5 Merck Recent Development 7.3 Parker Hannifin 7.3.1 Parker Hannifin Company Details 7.3.2 Parker Hannifin Business Overview 7.3.3 Parker Hannifin Viral Inactivation Introduction 7.3.4 Parker Hannifin Revenue in Viral Inactivation Business (2017-2022) 7.3.5 Parker Hannifin Recent Development 7.4 Sartorius 7.4.1 Sartorius Company Details 7.4.2 Sartorius Business Overview 7.4.3 Sartorius Viral Inactivation Introduction 7.4.4 Sartorius Revenue in Viral Inactivation Business (2017-2022) 7.4.5 Sartorius Recent Development 7.5 SGS 7.5.1 SGS Company Details 7.5.2 SGS Business Overview 7.5.3 SGS Viral Inactivation Introduction 7.5.4 SGS Revenue in Viral Inactivation Business (2017-2022) 7.5.5 SGS Recent Development 7.6 Charles River Laboratories International 7.6.1 Charles River Laboratories International Company Details 7.6.2 Charles River Laboratories International Business Overview 7.6.3 Charles River Laboratories International Viral Inactivation Introduction 7.6.4 Charles River Laboratories International Revenue in Viral Inactivation Business (2017-2022) 7.6.5 Charles River Laboratories International Recent Development 7.7 Clean Cells 7.7.1 Clean Cells Company Details 7.7.2 Clean Cells Business Overview 7.7.3 Clean Cells Viral Inactivation Introduction 7.7.4 Clean Cells Revenue in Viral Inactivation Business (2017-2022) 7.7.5 Clean Cells Recent Development 7.8 Rad Source Technologies 7.8.1 Rad Source Technologies Company Details 7.8.2 Rad Source Technologies Business Overview 7.8.3 Rad Source Technologies Viral Inactivation Introduction 7.8.4 Rad Source Technologies Revenue in Viral Inactivation Business (2017-2022) 7.8.5 Rad Source Technologies Recent Development 7.9 Texcell 7.9.1 Texcell Company Details 7.9.2 Texcell Business Overview 7.9.3 Texcell Viral Inactivation Introduction 7.9.4 Texcell Revenue in Viral Inactivation Business (2017-2022) 7.9.5 Texcell Recent Development 7.10 Viral Inactivated Plasma Systems 7.10.1 Viral Inactivated Plasma Systems Company Details 7.10.2 Viral Inactivated Plasma Systems Business Overview 7.10.3 Viral Inactivated Plasma Systems Viral Inactivation Introduction 7.10.4 Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2017-2022) 7.10.5 Viral Inactivated Plasma Systems Recent Development 7.11 Wuxi Pharmatech (Cayman) 7.11.1 Wuxi Pharmatech (Cayman) Company Details 7.11.2 Wuxi Pharmatech (Cayman) Business Overview 7.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Introduction 7.11.4 Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2017-2022) 7.11.5 Wuxi Pharmatech (Cayman) Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer
List of Tables Table 1. Viral Inactivation Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Viral Inactivation Market Trends Table 3. Viral Inactivation Market Drivers Table 4. Viral Inactivation Market Challenges Table 5. Viral Inactivation Market Restraints Table 6. Global Viral Inactivation Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Viral Inactivation Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Viral Inactivation Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Viral Inactivation Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Viral Inactivation Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Viral Inactivation Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Viral Inactivation Revenue Share by Player, 2017-2022 Table 13. Global Viral Inactivation Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Viral Inactivation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Inactivation as of 2021) Table 15. Top Players of Viral Inactivation in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Viral Inactivation Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Viral Inactivation Players in United States Market, Ranking by Revenue (2021) Table 20. United States Viral Inactivation Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Viral Inactivation Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Viral Inactivation Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Viral Inactivation Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Viral Inactivation Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Viral Inactivation Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Viral Inactivation Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Viral Inactivation Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Viral Inactivation Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Viral Inactivation Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Danaher Company Details Table 31. Danaher Business Overview Table 32. Danaher Viral Inactivation Product Table 33. Danaher Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Table 34. Danaher Recent Development Table 35. Merck Company Details Table 36. Merck Business Overview Table 37. Merck Viral Inactivation Product Table 38. Merck Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Table 39. Merck Recent Development Table 40. Parker Hannifin Company Details Table 41. Parker Hannifin Business Overview Table 42. Parker Hannifin Viral Inactivation Product Table 43. Parker Hannifin Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Table 44. Parker Hannifin Recent Development Table 45. Sartorius Company Details Table 46. Sartorius Business Overview Table 47. Sartorius Viral Inactivation Product Table 48. Sartorius Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Table 49. Sartorius Recent Development Table 50. SGS Company Details Table 51. SGS Business Overview Table 52. SGS Viral Inactivation Product Table 53. SGS Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Table 54. SGS Recent Development Table 55. Charles River Laboratories International Company Details Table 56. Charles River Laboratories International Business Overview Table 57. Charles River Laboratories International Viral Inactivation Product Table 58. Charles River Laboratories International Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Table 59. Charles River Laboratories International Recent Development Table 60. Clean Cells Company Details Table 61. Clean Cells Business Overview Table 62. Clean Cells Viral Inactivation Product Table 63. Clean Cells Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Table 64. Clean Cells Recent Development Table 65. Rad Source Technologies Company Details Table 66. Rad Source Technologies Business Overview Table 67. Rad Source Technologies Viral Inactivation Product Table 68. Rad Source Technologies Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Table 69. Rad Source Technologies Recent Development Table 70. Texcell Company Details Table 71. Texcell Business Overview Table 72. Texcell Viral Inactivation Product Table 73. Texcell Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Table 74. Texcell Recent Development Table 75. Viral Inactivated Plasma Systems Company Details Table 76. Viral Inactivated Plasma Systems Business Overview Table 77. Viral Inactivated Plasma Systems Viral Inactivation Product Table 78. Viral Inactivated Plasma Systems Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Table 79. Viral Inactivated Plasma Systems Recent Development Table 80. Wuxi Pharmatech (Cayman) Company Details Table 81. Wuxi Pharmatech (Cayman) Business Overview Table 82. Wuxi Pharmatech (Cayman) Viral Inactivation Product Table 83. Wuxi Pharmatech (Cayman) Revenue in Viral Inactivation Business (2017-2022) & (US$ Million) Table 84. Wuxi Pharmatech (Cayman) Recent Development Table 85. Research Programs/Design for This Report Table 86. Key Data Information from Secondary Sources Table 87. Key Data Information from Primary Sources List of Figures Figure 1. Viral Inactivation Product Picture Figure 2. Global Viral Inactivation Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Viral Inactivation Market Size 2017-2028 (US$ Million) Figure 4. United States Viral Inactivation Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Viral Inactivation Market Size 2017-2028 (US$ Million) Figure 6. United States Viral Inactivation Market Share in Global 2017-2028 Figure 7. Viral Inactivation Report Years Considered Figure 8. Product Picture of Kits and Reagents Figure 9. Product Picture of Services Figure 10. Product Picture of Viral Inactivation Systems and Accessories Figure 11. Global Viral Inactivation Market Share by Type in 2022 & 2028 Figure 12. Global Viral Inactivation Market Size by Type (2017-2028) & (US$ Million) Figure 13. Global Viral Inactivation Market Share by Type (2017-2028) Figure 14. United States Viral Inactivation Market Share by Type in 2022 & 2028 Figure 15. United States Viral Inactivation Market Size by Type (2017-2028) & (US$ Million) Figure 16. United States Viral Inactivation Market Share by Type (2017-2028) Figure 17. Product Picture of Blood and Blood Products Figure 18. Product Picture of Cellular and Gene Therapy Products Figure 19. Product Picture of Stem Cell Products Figure 20. Product Picture of Tissue and Tissue Products Figure 21. Product Picture of Vaccines and Therapeutics Figure 22. Global Viral Inactivation Market Share by Application in 2022 & 2028 Figure 23. Global Viral Inactivation Market Size by Application (2017-2028) & (US$ Million) Figure 24. Global Viral Inactivation Market Share by Application (2017-2028) Figure 25. United States Viral Inactivation Market Share by Application in 2022 & 2028 Figure 26. United States Viral Inactivation Market Size by Application (2017-2028) & (US$ Million) Figure 27. United States Viral Inactivation Market Share by Application (2017-2028) Figure 28. North America Viral Inactivation Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. U.S. Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. Canada Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. Europe Viral Inactivation Market Size Growth Rate 2017-2028 (US$ Million) Figure 32. Germany Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. France Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. U.K. Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Italy Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Russia Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Asia-Pacific Viral Inactivation Market Size Growth Rate 2017-2028 (US$ Million) Figure 38. China Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Japan Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. South Korea Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. India Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Australia Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Taiwan Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Indonesia Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Thailand Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Malaysia Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Philippines Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Latin America Viral Inactivation Market Size Growth Rate 2017-2028 (US$ Million) Figure 49. Mexico Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Brazil Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Argentina Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Middle East & Africa Viral Inactivation Market Size Growth Rate 2017-2028 (US$ Million) Figure 53. Turkey Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. UAE Viral Inactivation Market Size Growth Rate (2017-2028) & (US$ Million) Figure 56. Danaher Revenue Growth Rate in Viral Inactivation Business (2017-2022) Figure 57. Merck Revenue Growth Rate in Viral Inactivation Business (2017-2022) Figure 58. Parker Hannifin Revenue Growth Rate in Viral Inactivation Business (2017-2022) Figure 59. Sartorius Revenue Growth Rate in Viral Inactivation Business (2017-2022) Figure 60. SGS Revenue Growth Rate in Viral Inactivation Business (2017-2022) Figure 61. Charles River Laboratories International Revenue Growth Rate in Viral Inactivation Business (2017-2022) Figure 62. Clean Cells Revenue Growth Rate in Viral Inactivation Business (2017-2022) Figure 63. Rad Source Technologies Revenue Growth Rate in Viral Inactivation Business (2017-2022) Figure 64. Texcell Revenue Growth Rate in Viral Inactivation Business (2017-2022) Figure 65. Viral Inactivated Plasma Systems Revenue Growth Rate in Viral Inactivation Business (2017-2022) Figure 66. Wuxi Pharmatech (Cayman) Revenue Growth Rate in Viral Inactivation Business (2017-2022) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed
Danaher Merck Parker Hannifin Sartorius SGS Charles River Laboratories International Clean Cells Rad Source Technologies Texcell Viral Inactivated Plasma Systems Wuxi Pharmatech (Cayman)
Virtual Customer Premises Equipment (V-CPE) market is segmented by region (country), players, by ... Read More
Virtual Data Room market is segmented by region (country), players, by Type and by Application. P ... Read More
Virtual Reality market is segmented by region (country), players, by Type and by Application. Pla ... Read More
Virtualized Evolved Packet Core (vEPC) market is segmented by region (country), players, by Type ... Read More